1-(6-Chloro-2'-fluoro[1,1'-biphenyl]-3-yl)-3-(1-(2-chloroacetyl)piperidin-4-yl)urea

ID: ALA5276701

Chembl Id: CHEMBL5276701

Max Phase: Preclinical

Molecular Formula: C20H20Cl2FN3O2

Molecular Weight: 424.30

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C(Nc1ccc(Cl)c(-c2ccccc2F)c1)NC1CCN(C(=O)CCl)CC1

Standard InChI:  InChI=1S/C20H20Cl2FN3O2/c21-12-19(27)26-9-7-13(8-10-26)24-20(28)25-14-5-6-17(22)16(11-14)15-3-1-2-4-18(15)23/h1-6,11,13H,7-10,12H2,(H2,24,25,28)

Standard InChI Key:  MDZGEOYSIXOSKF-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA5276701

    ---

Associated Targets(Human)

NCI-H358 (882 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NCI-H23 (49055 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
A549 (127892 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NCI-H2228 (1030 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 424.30Molecular Weight (Monoisotopic): 423.0917AlogP: 4.50#Rotatable Bonds: 4
Polar Surface Area: 61.44Molecular Species: NEUTRALHBA: 2HBD: 2
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: 13.40CX Basic pKa: CX LogP: 3.29CX LogD: 3.29
Aromatic Rings: 2Heavy Atoms: 28QED Weighted: 0.71Np Likeness Score: -1.89

References

1. Cheng R, Lv X, Bu H, Xu Q, Wu J, Xie K, Tang J, Wang L, Zhuang J, Zhang Y, Zhang Y, Yan C, Lai Y..  (2022)  Design, synthesis, and evaluation of 4(1H)-quinolinone and urea derivatives as KRASG12C inhibitors with potent antitumor activity against KRAS-mutant non-small cell lung cancer.,  244  [PMID:36228411] [10.1016/j.ejmech.2022.114808]

Source